Skip to main content

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

ORKA holding history

Oruka Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ORKA overviewAll 13F holders of ORKAFull Q2 2026 holdings

Shares (Q2 2026)
1,429,954
Value
$136.1M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ORKA by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,429,954$136.1M<0.1%+475,087+49.8%AddedHolders
Q1 2026954,867$46.8M<0.1%+12,360+1.3%AddedHolders
Q4 2025942,507$28.6M<0.1%+252,535+36.6%AddedHolders
Q3 2025689,972$13.3M<0.1%−17,434−2.5%ReducedHolders
Q2 2025707,406$7.93M<0.1%+354,821+100.6%AddedHolders
Q1 2025352,585$3.62M<0.1%+10,167+3.0%AddedHolders
Q4 2024342,418$6.64M<0.1%+328,434+2,348.6%AddedHolders
Q3 202413,984$342.8K<0.1%−147,751−91.4%ReducedHolders
Q2 2024161,735$619.5K<0.1%+19,386+13.6%AddedHolders
Q1 2024142,349$253.4K<0.1%00.0%UnchangedHolders
Q4 2023142,349$242.0K<0.1%00.0%UnchangedHolders
Q3 2023142,349$286.2K<0.1%−13,286−8.5%ReducedHolders
Q2 2023155,635$315.9K<0.1%00.0%UnchangedHolders
Q1 2023155,635$309.7K<0.1%00.0%UnchangedHolders
Q4 2022155,635$367.0K<0.1%−235−0.2%ReducedHolders
Q3 2022155,870$321.0K<0.1%+52,959+51.5%AddedHolders
Q2 2022102,911$256.0K<0.1%+6,585+6.8%AddedHolders
Q1 202296,326$221.0K<0.1%+968+1.0%AddedHolders
Q4 202195,358$205.0K<0.1%00.0%UnchangedHolders
Q3 202195,358$282.0K<0.1%+7,699+8.8%AddedHolders
Q2 202187,659$305.0K<0.1%+8,508+10.7%AddedHolders
Q1 202179,151$288.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.